4
Changes in Ownership
Viking Therapeutics, Inc. Filed Acc 0001209191-23-030794
Director sold 16,000 shares at $24.00 ($384,000)
- Director acquired 16,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
MACARTNEY LAWSON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-16 | Exercise or conversion : show line 1 in the form | +16,000 | $1.19 | $19,040 | 63,965 | D |
| 2023-05-16 | Sale : show line 2 in the form | −16,000 | $24.00 | $384,000 | 47,965 | D |
| Open-market sales · 16,000 sh · avg $24.00 · $384,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-16 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −16,000 | 0 | D |
Loading xslF345X04/doc4.xml…